What are the normal serum 17‑hydroxyprogesterone (17‑OHP) ranges in neonates based on gestational age and timing of sample collection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal 17-Hydroxyprogesterone Levels in Neonates by Age and Gestational Age

Normal 17-OHP levels in neonates must be stratified by gestational age rather than birth weight, as 17-OHP levels are inversely correlated with gestational age and decrease rapidly during the first postnatal days. 1

Key Physiological Principles

17-OHP levels are normally high at birth and decrease rapidly during the first few postnatal days in healthy infants, while they increase over time in infants with congenital adrenal hyperplasia (CAH). 1 This creates a critical window where:

  • Diagnostic accuracy is poor in the first 2 days of life, particularly problematic with early hospital discharge
  • Premature, sick, or stressed infants have significantly higher 17-OHP levels than term infants, requiring adjusted cutoffs 1

Gestational Age-Based Reference Ranges

The Endocrine Society Clinical Practice Guidelines strongly recommend standardization of screening tests with norms stratified by gestational age rather than birth weight, as 17-OHP levels correlate much better with gestational age. 1 This approach has improved positive predictive values in The Netherlands and Switzerland. 1

Pattern by Gestational Age:

Recent research demonstrates clear inverse correlation:

  • Very preterm (<32 weeks): Median 19.21 nmol/L (range 8.07-24.00 nmol/L) 2
  • Moderately preterm (32-<36 weeks): Median 12.35 nmol/L (range 6.81-18.00 nmol/L) 2
  • Late preterm (36-<37 weeks): Median 8.58 nmol/L (range 5.66-13.80 nmol/L) 2
  • Term infants: Median 5.60 nmol/L (range 3.57-8.51 nmol/L) 2
  • Post-term: Median 3.34 nmol/L (range 2.58-5.23 nmol/L) 2

The correlation is binomial: y = 0.1055x² - 2.4576x + 17.689 (where y = 17-OHP level, x = gestational age in weeks). 2

Age at Sampling Impact

Timing of sample collection significantly affects 17-OHP levels:

  • Samples collected at 48-<72 hours have lower 17-OHP levels than samples collected ≥72 hours across all birth weight groups 3
  • The 99.8th percentile provides better discrimination between affected and unaffected newborns than the 99.5th percentile 3
  • Using the 99.8th percentile cutoff: positive predictive value was 5.6% for early samples (48-<72h) vs 14.1% for later samples (≥72h) 3

Serum 17-OHP in Healthy Term Newborns:

  • First week of life (4-7 days): Mean 4.67 ± 2.6 ng/mL 4
  • Fourth week of life (26-30 days): Mean 4.49 ± 2.7 ng/mL 4
  • No significant change between first and fourth week (p > 0.05) 4

Diagnostic Cutoffs for CAH Screening

Baseline 17-OHP Interpretation (from Endocrine Society Guidelines):

  • >300 nmol/L (>10,000 ng/dL): Likely Classic CAH 1
  • 6-300 nmol/L (200-10,000 ng/dL): Likely Nonclassic CAH 1
  • <6 nmol/L (<200 ng/dL): Likely Unaffected or NCCAH 1

Post-ACTH Stimulation Test:

  • >300 nmol/L (>10,000 ng/dL): Classic CAH 1
  • 31-300 nmol/L (1,000-10,000 ng/dL): Likely NCCAH 1
  • <50 nmol/L (<1,666 ng/dL): Unaffected or Heterozygote 1

Critical Clinical Caveats

Special Populations Requiring Higher Cutoffs:

  1. Premature infants: Generate many false positives unless higher cutoffs used 1
  2. Sick or stressed infants: Have true elevations in 17-OHP levels 1
  3. Low birth weight infants: Show significantly higher 17-OHP levels than normal birth weight infants at same gestational age 2

Antenatal Corticosteroids:

Infants exposed to antenatal corticosteroids (for lung maturation) may have reduced 17-OHP levels, though effects are inconsistent. All such infants should be retested after several days of life. 1

Practical Implementation

Most U.S. laboratories use birth weight-adjusted cutoffs, but the evidence strongly supports gestational age stratification as superior. 1 The 99.5th percentile is typically used to set initial cutoff values, resulting in approximately 1% positive screens. 1

Application of gestational age and sampling time-adjusted cutoffs can:

  • Reduce recall rates to 0.9-1.75% 5
  • Reduce positive rates by 30% 6
  • Increase positive predictive value by 40% 6
  • Reduce false-positive rates significantly while maintaining sensitivity 3

The relationship between 17-OHP and both gestational age and birth weight is significantly negatively correlated (correlation coefficients -16.40 and -10.10 respectively, both p<0.001). 2

References

Research

Reference intervals for serum 17α-hydroxyprogesterone and ultrasonographic adrenal gland sizes in healthy newborns.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2020

Research

Establishing 17-Hydroxyprogesterone Cutoff Values for Congenital Adrenal Hyperplasia in Preterm, Low Birth Weight, and Sick Newborns.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.